Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High level of primary drug resistance in Mali.

HIV medicine - 1 Jul 2010

Haidara A, Chamberland A, Sylla M, Aboubacrine S A, Cissé M, Traore H A, Maiga M Y, Tounkara A, Nguyen V K, Tremblay C

Abstract excerpt

BACKGROUND: As access to antiretroviral drugs increases in developing countries, it will become increasingly important to monitor the emergence of resistance and to define the molecular pathways involved to identify optimal therapeutic regimens. METHODS: We performed genotypic resistance testing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active
Share to Drug Resistance, Multiple, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Infections

Share to HIV Reverse Transcriptase

Share to RNA, Viral

Source

Identifiers

PMID: 20146734
DOI: 10.1111/j.1468-1293.2009.00806.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20146734-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High level of primary drug resistance in Mali.PMID 20146734Read ↗

Evolution of genetic diversity and drug resistance mutations in HIV-1 among untreated patients from Mali between 2005 and 2006.Semantic proximity Read ↗

Transmitted antiretroviral drug resistance in newly HIV-infected and untreated patients in Ségou and Bamako, Mali.Semantic proximity Read ↗

[Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].Semantic proximity Read ↗

High level of HIV-1 resistance in patients failing long-term first-line antiretroviral therapy in Mali.Semantic proximity Read ↗

Drug resistance mutations in HIV type 1 isolates from patients failing antiretroviral therapy in Morocco.Semantic proximity Read ↗

Updated prevalence of genotypic resistance among HIV-1 positive patients naïve to antiretroviral therapy: a single center analysis.Semantic proximity Read ↗

Limited evolution but increasing trends of primary non-nucleoside reverse transcriptase inhibitor resistance mutations in therapy-naive HIV-1-infected individuals in India.Semantic proximity Read ↗

Profile of primary resistance in HIV-1-infected treatment-naive individuals from Western India.Semantic proximity Read ↗

Primary HIV-1 drug resistance and polymorphic patterns among injecting drug users (IDUs) in Chennai, Southern India.Semantic proximity Read ↗

Zero prevalence of primary drug resistance-associated mutations to protease inhibitors in HIV-1 drug-naive patients in and around Aligarh, India.Semantic proximity Read ↗

High prevalence of PI resistance in patients failing second-line ART in Vietnam.Semantic proximity Read ↗

Drug resistance mutations and genetic diversity in adults treated for HIV type 1 infection in Mauritania.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.